Barclays Capital Securities Limited Post-Stabilisation Period Announcement (2927Z)
December 13 2017 - 12:50PM
UK Regulatory
TIDMSBRE
RNS Number : 2927Z
Barclays Capital Securities Limited
13 December 2017
13 December 2017
Not for release, publication or distribution, in whole or in
part, directly or indirectly, in or into the United States of
America, Australia, Canada, Japan or South Africa or any
jurisdiction in which such distribution would be unlawful.
Sabre Insurance Group plc
Pre-Stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 06
December 2017 Barclays Bank PLC ('Barclays') (Ben West; telephone:
+44 20 7773 9531) hereby gives notice that as Stabilising
Coordinator, the Stabilisation Manager named below undertook
stabilisation (within the meaning of Article 3.2(d) of the Market
Abuse Regulation (EU/596/2014) and of the rules of the Financial
Conduct Authority) in relation to the offer of the following
securities, as set out below.
The securities:
-----------------------------------------------------------------------------------------
Issuer: Sabre Insurance Group plc
----------------------------- ----------------------------------------------------------
Aggregate nominal 125,000,000 Ordinary Shares (excluding the over-allotment
amount/Offering size: option)
----------------------------- ----------------------------------------------------------
Description: Ordinary Shares in Sabre Insurance Group plc
with a nominal value of GBP0.001. ISIN: GB00BYWVDP49
----------------------------- ----------------------------------------------------------
Offer price: 230p
----------------------------- ----------------------------------------------------------
Stabilisation:
-----------------------------------------------------------------------------------------
Stabilisation Manager: Barclays Capital Securities Limited, 5 The North
Colonnade, Canary Wharf, London, E14 4BB, United
Kingdom
----------------------------- ----------------------------------------------------------
Stabilisation started 6(th) December 2017
on:
----------------------------- ----------------------------------------------------------
Stabilisation last 13(th) December 2017
occurred on:
----------------------------- ----------------------------------------------------------
Stabilisation transactions: Although stabilisation bids were made, no stabilisation
transactions were carried out
----------------------------- ----------------------------------------------------------
In connection with the offer of the above securities, the
Stabilisation Manager may over-allot the securities or effect
transactions with a view to supporting the market price of the
securities at a level higher than that which might otherwise
prevail. However, stabilisation may not necessarily occur and any
stabilisation action, if begun, may cease at any time. Any
stabilisation action or over--allotment shall be conducted in
accordance with all applicable laws and rules.
This announcement is for information purposes only and does not
constitute an invitation or offer to underwrite, subscribe for or
otherwise acquire or dispose of any securities of the Issuer in any
jurisdiction.
This announcement is only addressed to and directed at persons
outside the United Kingdom and persons in the United Kingdom who
have professional experience in matters related to investments
falling within Article 19(5) of the Financial Services and Markets
Act 2000 (Financial Promotion) Order 2005 (the Order) or who are
high net worth persons falling within Article 49 of the Order and
must not be acted on or relied on by other persons in the United
Kingdom.
In addition, if and to the extent that this announcement is
communicated in any EEA Member State that has implemented Directive
2003/71/EC (together with any applicable implementing measures in
any Member State, the "Prospectus Directive") before the
publication of a prospectus in relation to the securities to which
this announcement relates which has been approved by the competent
authority in that Member State in accordance with the Prospectus
Directive (or which has been approved by a competent authority in
another Member State and notified to the competent authority in
that Member State in accordance with the Prospectus Directive),
this announcement is only addressed to and directed at persons in
that Member State who are qualified investors within the meaning of
the Prospectus Directive (or who are other persons to whom the
offer may lawfully be addressed) and must not be acted on or relied
on by other persons in that Member State.
This announcement does not constitute, or form part of, an offer
to sell, or a solicitation of an offer to purchase any securities
in the United States or any other jurisdiction. The securities
referred to herein have not been and will not be registered under
the U.S. Securities Act of 1933, as amended (the "Securities Act"),
and may not be offered or sold in the United States except to
"qualified institutional buyers" as defined in, and in reliance on,
Rule 144A under the Securities Act or another exemption from, or
transaction not subject to, the registration requirements of the
Securities Act. All offers and sales of securities outside of the
United States will be made in reliance on, and in compliance with,
Regulation S under the Securities Act. There is no intention to
register any securities referred to herein in the United States or
to make a public offering of the securities in the United
States.
This information is provided by RNS
The company news service from the London Stock Exchange
END
STAGGGBCPUPMGMW
(END) Dow Jones Newswires
December 13, 2017 12:50 ET (17:50 GMT)
Sabre Insurance (LSE:SBRE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sabre Insurance (LSE:SBRE)
Historical Stock Chart
From Apr 2023 to Apr 2024